Abstract
Background: The prognosis of metastatic melanoma has drastically improved in recent years with the evolution of effective systemic therapies (EST). The impact of EST on the role of surgery in Stage IV melanoma is unclear. We sought to characterise the patterns and outcomes of surgery in patients with Stage IV melanoma before and after the introduction of EST.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
